John Frazer to Humans
This is a "connection" page, showing publications John Frazer has written about Humans.
Connection Strength
0.502
-
Diverse Epithelial Lymphocytes in Zebrafish Revealed Using a Novel Scale Biopsy Method. J Immunol. 2024 Dec 15; 213(12):1902-1914.
Score: 0.055
-
Dynamic Changes in Lymphocyte Populations Establish Zebrafish as a Thymic Involution Model. J Immunol. 2024 Jun 01; 212(11):1733-1743.
Score: 0.053
-
Tackling Acute Lymphoblastic Leukemia-One Fish at a Time. Int J Mol Sci. 2019 Oct 25; 20(21).
Score: 0.039
-
Targeted sequencing of candidate genes of dyslipidemia in Punjabi Sikhs: Population-specific rare variants in GCKR promote ectopic fat deposition. PLoS One. 2019; 14(8):e0211661.
Score: 0.038
-
Isolating Malignant and Non-Malignant B Cells from lck:eGFP Zebrafish. J Vis Exp. 2019 02 22; (144).
Score: 0.037
-
Molecularly distinct models of zebrafish Myc-induced B cell leukemia. Leukemia. 2019 02; 33(2):559-562.
Score: 0.037
-
Excellent outcomes in children and adolescents with CNS+ Burkitt lymphoma or other mature B-NHL using only intrathecal and systemic chemoimmunotherapy: results from FAB/LMB96 and COG ANHL01P1. Br J Haematol. 2019 04; 185(2):374-377.
Score: 0.036
-
Simultaneous B and T cell acute lymphoblastic leukemias in zebrafish driven by transgenic MYC: implications for oncogenesis and lymphopoiesis. Leukemia. 2019 02; 33(2):333-347.
Score: 0.036
-
Creation of a human T-ALL cell line online database. Leuk Lymphoma. 2017 11; 58(11):2728-2730.
Score: 0.033
-
Molecular genetics of childhood, adolescent and young adult non-Hodgkin lymphoma. Br J Haematol. 2016 05; 173(4):582-96.
Score: 0.030
-
Shared acquired genomic changes in zebrafish and human T-ALL. Oncogene. 2011 Oct 13; 30(41):4289-96.
Score: 0.022
-
A pediatric B lineage leukemia with coincident MYC and MLL translocations. J Pediatr Hematol Oncol. 2011 Mar; 33(2):158-60.
Score: 0.021
-
Heritable T-cell malignancy models established in a zebrafish phenotypic screen. Leukemia. 2009 Oct; 23(10):1825-35.
Score: 0.019
-
Association of Combined Focal 22q11.22 Deletion and IKZF1 Alterations With Outcomes in Childhood Acute Lymphoblastic Leukemia. JAMA Oncol. 2021 Oct 01; 7(10):1521-1528.
Score: 0.011
-
Impact of persistent minimal residual disease post-consolidation therapy in children and adolescents with advanced Burkitt leukaemia: a Children's Oncology Group Pilot Study Report. Br J Haematol. 2015 Aug; 170(3):367-71.
Score: 0.007
-
Rituximab with chemotherapy in children and adolescents with central nervous system and/or bone marrow-positive Burkitt lymphoma/leukaemia: a Children's Oncology Group Report. Br J Haematol. 2014 Nov; 167(3):394-401.
Score: 0.007
-
UNC569, a novel small-molecule mer inhibitor with efficacy against acute lymphoblastic leukemia in vitro and in vivo. Mol Cancer Ther. 2013 Nov; 12(11):2367-77.
Score: 0.006
-
VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia. Leukemia. 2014 Jan; 28(1):216-20.
Score: 0.006
-
Zebrafish screen identifies novel compound with selective toxicity against leukemia. Blood. 2012 Jun 14; 119(24):5621-31.
Score: 0.006
-
Unexpected cytogenetic finding in acute lymphoblastic leukemia: a case of del(5q) with a cryptic t(12;21). Cancer Genet Cytogenet. 2006 Jul 15; 168(2):177-8.
Score: 0.004